WANBURY
Back to Income Statement
|
WANBURY Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹500 Cr | ₹511 Cr | ₹393 Cr | ₹367 Cr | ₹391 Cr |
What is the latest Revenue of WANBURY ?
Year | Revenue |
---|---|
Mar2024 | ₹500 Cr |
Mar2023 | ₹511 Cr |
Mar2022 | ₹393 Cr |
Mar2021 | ₹367 Cr |
Mar2020 | ₹391 Cr |
How is Revenue of WANBURY Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹500 Cr | -2.26 | |
Mar2023 | ₹511 Cr | 30.23 | |
Mar2022 | ₹393 Cr | 6.82 | |
Mar2021 | ₹367 Cr | -6.11 | |
Mar2020 | ₹391 Cr | - |
Compare Revenue of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹720.5 Cr | -8.8% | -21.8% | 57.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,303.0 Cr | -5.1% | -9.4% | 29.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹143,389.0 Cr | -7.3% | -10.9% | 53% | Stock Analytics | |
CIPLA | ₹114,645.0 Cr | -1.4% | -6.7% | -1.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,449.5 Cr | -9% | -14.4% | 1.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹91,587.4 Cr | -7% | -5% | 22.6% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -8.8% |
-21.8% |
57.1% |
SENSEX | 0.1% |
-3.6% |
7.9% |
You may also like the below Video Courses